financetom
Business
financetom
/
Business
/
Lufthansa slashes 2024 profit target, eyes cutbacks on low yields
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lufthansa slashes 2024 profit target, eyes cutbacks on low yields
Jul 12, 2024 4:04 AM

FRANKFURT (Reuters) -German airline group Deutsche Lufthansa on Friday slashed its earnings guidance for the year and said it would have a far-reaching efficiency programme, citing low yields in Asia and problems in operations at home.

Lufthansa now expects adjusted 2024 earnings before interest and taxes between 1.4 billion euros ($1.5 billion) and 1.8 billion, down from a previous target of about 2.2 billion, it said in a statement.

"A comprehensive turnaround program is being launched", affecting its core Lufthansa brand and regional carrier Cityline, the company said.

It also reported that group second-quarter adjusted EBIT fell by more than a third to 686 million euros.

"A market-related decline in yields in all traffic regions - especially in Asia - had a negative impact," the carrier said.

It said that its core Lufthansa brand was particularly hit by negative market trends.

There were also "inefficiencies in the flight operations" of Lufthansa and Cityline, and delayed aircraft deliveries to deal with, the group added.

($1 = 0.9184 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Maple Leaf Foods Q3 Total Company Earnings and Sales Rise; Lowers Quarterly Dividend to $0.19
Maple Leaf Foods Q3 Total Company Earnings and Sales Rise; Lowers Quarterly Dividend to $0.19
Nov 5, 2025
07:21 AM EST, 11/05/2025 (MT Newswires) -- Maple Leaf Foods ( MLFNF ) on Wednesday reported an increase in total company earnings and sales in the third quarter, but lowered its quarterly dividend to $0.19 per share. For the three-months ended Sept. 30, earnings were $43.1 million or $0.35 earnings per basic share compared with $17.7 million or $0.14 earnings...
Royalty Pharma Q3 Portfolio Receipts up 11%, guidance raised
Royalty Pharma Q3 Portfolio Receipts up 11%, guidance raised
Nov 5, 2025
Overview * Royalty Pharma Q3 2025 Portfolio Receipts grow 11% yr/yr to $814 mln * Adjusted EBITDA for Q3 2025 beats analyst expectations * Company raises full-year 2025 guidance for Portfolio Receipts to $3.2-$3.25 bln Outlook * Royalty Pharma ( RPRX ) raises 2025 Portfolio Receipts guidance to $3,200 mln-$3,250 mln * Company expects 2025 Portfolio Receipts growth of 14%...
Viridian Therapeutics secures $889 mln financing
Viridian Therapeutics secures $889 mln financing
Nov 5, 2025
Overview * Viridian Q3 revenue rise driven by license and collaboration revenue * Company secured up to $889 mln in financing, enhancing cash position to $887.9 mln * Submitted BLA for veligrotug to FDA, commercial launch expected mid-2026 if approved Outlook * Viridian expects veligrotug U.S. commercial launch in mid-2026, pending FDA approval * Company anticipates VRDN-003 topline data in...
Kornit Digital Q3 revenue up 5%, beats estimates
Kornit Digital Q3 revenue up 5%, beats estimates
Nov 5, 2025
Overview * Kornit Digital ( KRNT ) Q3 revenue grows 5% yr/yr, beating analyst expectations * Adjusted EBITDA for Q3 was positive at $1.1 mln, reflecting operational improvements * Company expands Apollo and Atlas MAX PLUS installations, boosting bulk apparel production Outlook * Company expects Q4 2025 revenue between $56 mln and $60 mln * Kornit Digital ( KRNT )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved